Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Freiburg, Germany.
J Antimicrob Chemother. 2011 Feb;66(2):381-6. doi: 10.1093/jac/dkq424. Epub 2010 Nov 23.
The main objective was to study the impact of in-hospital bacteraemia caused by Staphylococcus aureus on mortality within 90 days after admission. We compared methicillin-resistant S. aureus (MRSA) with methicillin-susceptible S. aureus (MSSA).
The study population consisted of adult residents of Tayside, Scotland, UK, from 1 January 2005 to 30 September 2006 who had a new admission to Ninewells Hospital between 1 July 2005 and 30 June 2006. All patients (n = 3132) in the same wards as the patients infected with S. aureus were included. We addressed key weaknesses in previous studies by using a cohort design and applying a multistate model, which addressed the temporal dynamics. Critically, the model recognized that death and discharge from the hospital are competing events and that delay in discharge independently increases the risk of death.
The cohort included 3132 patients, of whom 494 died within 90 days after admission, 34 developed MRSA bacteraemia and 26 MSSA bacteraemia in the hospital. In comparison with patients without S. aureus bacteraemia, the death hazard was 5.6 times greater with MRSA [95% confidence interval (CI) 3.36-9.41] and 2.7 times greater with MSSA bacteraemia (95% CI 1.33-5.39). After adjustment for co-morbidity, hospitalization, age and sex, the death hazard was 2.9 times greater with MRSA (95% CI 1.70-4.88) and 1.7 times greater with MSSA bacteraemia (95% CI 0.84-3.47).
Time-dependent models such as the proposed multistate model are necessary to address the temporal dynamics of admission, infection, discharge and death. The impact of S. aureus bacteraemia on mortality should be considered on two levels: the burden of disease, i.e. nosocomial infection with S. aureus bacteraemia, and the burden of resistance to methicillin.
本研究旨在探讨院内金黄色葡萄球菌(S. aureus)感染导致的菌血症对入院后 90 天内死亡率的影响。我们将耐甲氧西林金黄色葡萄球菌(MRSA)与甲氧西林敏感金黄色葡萄球菌(MSSA)进行了比较。
研究人群为 2005 年 1 月 1 日至 2006 年 9 月 30 日期间苏格兰泰赛德地区的成年住院患者,他们在 2005 年 7 月 1 日至 2006 年 6 月 30 日期间在 Ninewells 医院新入院。所有与感染 S. aureus 的患者在同一病房的患者均被纳入研究。我们采用队列设计和多状态模型来解决之前研究中的关键缺陷,该模型解决了时间动态问题。至关重要的是,该模型认识到死亡和出院是竞争事件,并且出院延迟会独立增加死亡风险。
该队列纳入了 3132 例患者,其中 494 例患者在入院后 90 天内死亡,34 例患者发生了 MRSA 菌血症,26 例患者发生了 MSSA 菌血症。与没有 S. aureus 菌血症的患者相比,MRSA 感染患者的死亡风险高 5.6 倍[95%置信区间(CI)为 3.36-9.41],MSSA 感染患者的死亡风险高 2.7 倍[95%CI 为 1.33-5.39]。在校正合并症、住院、年龄和性别后,MRSA 感染患者的死亡风险高 2.9 倍[95%CI 为 1.70-4.88],MSSA 感染患者的死亡风险高 1.7 倍[95%CI 为 0.84-3.47]。
需要采用时间依赖性模型(如所提出的多状态模型)来解决入院、感染、出院和死亡的时间动态问题。金黄色葡萄球菌菌血症对死亡率的影响应从两个层面考虑:即金黄色葡萄球菌菌血症引起的疾病负担和对甲氧西林的耐药负担。